At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 12 enrolled
Drug / intervention
32ppm Silver Particle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm
In Brief
A Phase 2 clinical trial evaluating 32ppm Silver Particle and Placebo for Healthy. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The investigators propose to study oral commercial silver nanoparticle products on human enzyme activity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedJul 2011
Primary CompletionNov 2011
TodayJul 2026
First PostedJul 29, 2011
Enrollment StartJul 1, 2011
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.9 years ago
Interventions
32ppm Silver Particledrug
Oral silver dose of 32ppm
Placebodrug
Sterile Water No Silver